早期慢性胰腺炎研究热点与前沿:基于Web of Science数据的实证研究OA
Research hotspots and frontiers of early chronic pancreatitis:An empirical research based on the data of Web of Science
目的 了解早期慢性胰腺炎(ECP)的研究方向、热点与前沿.方法 在 Web of Science的核心合集中检索与ECP相关的文献,并应用CiteSpace6.2软件进行作者、国家、机构和关键词的共现分析.通过分析被引作者、被引文献、被引期刊等制作可视化图谱,以便更全面地了解ECP研究领域的合作关系、研究热点和发展趋势.结果 共获得文献48篇.日本是发文量最多的国家;主要研究机构包括日本医科大学、东北大学、哈佛大学、自治医科大学等;高产作者包括SHIMOSEGAWA T、HIROTA M、AGAWA S、YAMAWAKI H等;高频关键词包括慢性胰腺炎、早期慢性胰腺炎、分期、内镜超声学、疾病等;聚类方向分为早期、功能性消化不良、囊性纤维化跨膜调节因子、磁共振成像等.结论 利用CiteSpace软件对ECP进行可视化分析可知超声内镜技术诊断ECP具有较高的灵敏度,可将其用于大规模的流行病学调查或疾病管理.
Objective To understand the research direction,hotspots,and frontiers of early chronic pan-creatitis(ECP).Methods Relevant literature on ECP was retrieved from the Core Collection of Web of Sci-ence,and c-occurrence analysis of authors,countries,institutions,and keywords were conducted using CiteSpace6.2 software.Visual maps of cited authors,cited documents,and cited journals were created to com-prehensively understand the collaborative relationships,research hotspots,and trends in the field of ECP.Re-sults A total of 48 articles were obtained.Japan had the highest number of publications.The main research institutions included the Japan Medical University,Northeastern University,Harvard University,and Jichi Medical University.High-productivity authors included SHIMOSEGAWA T,HIROTA M,AGAWA S and YAMAWAKI H,etc.High-frequency keywords included chronic pancreatitis,early chronic pancreatitis,stag-ing,endoscopic ultrasonography,and disease.Cluster directions included early-stage,functional dyspepsia,cystic fibrosis transmembrane conductance regulator,and magnetic resonance imaging,etc.Conclusion Visual analysis of ECP using CiteSpace software revealed that endoscopic ultrasound technology has a high sensitivity in diagnosing ECP and can be used for large-scale epidemiological surveys or disease management.
陶晓生;史海涛;刘娜;赵平;乔璐;王进海;马师洋
西安交通大学第二附属医院消化内科,陕西 西安 710004
临床医学
早期慢性胰腺炎文献计量学可视化分析实证研究
Early chronic pancreatitisBibliometricsVisual analysisEmpirical research
《现代医药卫生》 2024 (010)
1637-1641 / 5
陕西省重点研发计划项目(2018SF-191).
评论